Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biolchim is an Italian agricultural inputs company focused on specialty plant nutrition, special fertilizers, and biostimulants for crop production. Founded in Italy in 1972, the company develops and markets products intended to improve nutrient uptake, nutrient use efficiency, abiotic stress tolerance, and crop quality in agriculture. Biolchim operates globally through the Biolchim Group and serves growers with foliar, fertigation, and crop-specific solutions rather than human therapeutics. In 2022, J.M. Huber Corporation acquired the Biolchim Group to expand Huber AgroSolutions' position in sustainable agricultural products. Although it works with biologically derived crop products, Biolchim is not a life science, biotech, pharma, or healthcare company in the human health sense.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biolchim.